C - Reactive Protein (CRP) Testing Market to Hit USD 4.0 Bn by 2031 Growing at a CAGR of 2.9%, Says Transparency Market Research

WILMINGTON, DE / ACCESSWIRE / April 18, 2023 / Transparency Market Research Inc. - The C-reactive protein (CRP) testing market was valued at USD 3.1 Bn in 2022 and is projected to exceed USD 4.0 Bn by 2031 with CAGR of 2.9%.

Surge in usage of C-reactive protein (CRP) testing to diagnose and monitor a wide range of inflammatory conditions is expected to propel the market. Testing for elevated CRP levels plays a vital role in monitoring chronic infectious diseases, especially in older adults, and improving effectiveness of therapy.

Download Sample Copy with Graphs & List of Figures @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1899

Advancement in CRP point-of-care testing (POCT) has led to development of kits that can diagnose infectious conditions early and guide effective management of the diseases. Introduction of POCT kits with enhanced sensitive and specificity is likely to broaden the market outlook.

Increase in focus on prevention of cardiovascular diseases is likely to boost the CRP point-of-care testing market. Rise in adoption of simple and low-cost methods to measure CRP levels in patients is a key market trend that is expected to offer significant business opportunities to companies. An instance is rising popularity of immunoturbidimetry tests. Extensive R&D in CRP kits based on immunoturbidimetry in the past few decades has generated substantial revenues for companies in the global C-reactive protein (CRP) testing industry.

Key Findings of Study

• Increase in Adoption of CRP Testing to Manage Inflammatory Diseases: Rise in adoption of C-reactive protein (CRP) testing to diagnose range of inflammatory disorders and autoimmune diseases is expected to bolster market growth. CRP testing is effective marker of chronic and systemic inflammation. Increase in trend of usage of CRP testing kits in the treatment/management of cardiovascular diseases and autoimmune disorders in the elderly is anticipated to accelerate market development. Among the various types of assays in the market, the immunoturbidimetry segment accounted for major share in 2022. Rise in adoption of immunoturbidimetry test in clinical laboratories to diagnose inflammatory conditions is estimated to bolster C-reactive protein (CRP) testing market growth.
• Demand for High-sensitivity Assays Presents Significant Business Opportunities: Companies are developing high-sensitive assays to enable clinicians in the early diagnosis of inflammatory diseases. Rise in demand for point-of-care tests for chronic inflammatory diseases is expected to offer significant revenues to companies. Surge in incidence of parasitic and zoonotic diseases and their associated morbidity and mortality rates are likely to favor the evolution of the C-reactive protein (CRP) testing market.

Get Customized Solution to Meet Your Research Requirements: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1899

Key Drivers

• Increase in incidence and prevalence of many inflammatory diseases, especially autoimmune diseases, across the globe is a key driver of the C-reactive protein (CRP) testing market. High burden of inflammatory bowel disease and rheumatoid arthritis (RA) has driven the need for sensitive assays for early diagnosis of the condition. Autoimmune disease has significant health burden and its prevalence is projected to increase in the next few years.
• Rise in demand for point-of-care (POC) diagnostic tests for a wide range of bacterial and viral infections is expected to bolster the C-reactive protein (CRP) testing market. Continuous advancements in analytical methods, such as biosensors and bioassays, are anticipated to enhance the sensitivity of point-of-care tests (POCT) of CRP in the patient population.

Regional Growth Dynamics

North America accounted for the leading market share in 2022. Rise in adoption of POCT for CRP testing is expected to propel the market in North America. Enhanced user convenience and rapid detection of elevated CRP levels in patients are key aspects that are likely to bolster the popularity of POCT assays. Rise in demand for simple and accurate kits for CRP testing in the region is estimated to accelerate C-reactive protein (CRP) testing market development from 2023 to 2031.

Surge in incidence of multiple inflammatory diseases in North America is expected to fuel the market in the region in the near future.

Asia Pacific is also a lucrative market for C-reactive protein (CRP) testing. Increase in trend of usage of CRP testing for early diagnosis of a wide spectrum of inflammatory disorders/conditions, including rheumatoid arthritis, CVD, cancer, and infections, is expected to bolster the market value during the forecast period.

Competition Landscape

Leading players are focusing on merger and acquisition and product portfolio expansion in order to consolidate their market position. Key companies are engaged in new product development in order to increase their customer base. Top players are expected to unveil advanced POCT kits in a bid to gain a competitive edge over others.

Prominent companies in the C-reactive protein (CRP) testing market are Agilent Technologies, Inc., Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, F.Hoffmann-La Roche Ltd., Creative Diagnostics, CTK Biotech Inc., Goldsite Diagnostics Inc., OptiBio Co., Ltd, and Getein Biotech, Inc.

Buy this Premium Research Report | Immediate Delivery Available at https://www.transparencymarketresearch.com/checkout.php?rep_id=1899<>

C- reactive Protein (CRP) Testing Market Segmentation

Stay Updated with Latest Healthcare Industry Research Reports:

• Syringes Market Trends
• Near-Infrared Fluorescence Imaging System Market Size
• Surgical Site Infections Market Share
• Cancer Immunotherapy Market Analysis
• Glioma Treatment Market Outlook
• Medical Lifting Slings Market Demand
• Mice Model Technologies Market Growth
• Peptide Therapeutics Market Analysis
• Diabetes Devices Market Forecast
• Teleradiology Market Report

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

SOURCE: Transparency Market Research inc.

ACCESSWIRE

News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.